These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 14281032)

  • 1. IPECAC BISMUTH IODIDE IN EXPERIMENTAL AMOEBIASIS.
    CHAUDHURI RN; SAHA TK; CHAUDHURI AD
    Bull Calcutta Sch Trop Med; 1964 Oct; 12():169. PubMed ID: 14281032
    [No Abstract]   [Full Text] [Related]  

  • 2. Emetine bismuth iodide in intestinal amoebiasis.
    SAHA TK; CHAUDHURI RN
    Bull Calcutta Sch Trop Med; 1963 Jan; 11():33. PubMed ID: 13976073
    [No Abstract]   [Full Text] [Related]  

  • 3. Symposium on the treatment of human amoebiasis. II. The treatment of intestinal amoebiasis with emetine bismuth iodide, glaucarubin, dichloroacet-hydroxy-methylanilide, camoform and various antibiotics.
    WOODRUFF AW; BELL S; SCHOFIELD FD
    Trans R Soc Trop Med Hyg; 1956 Mar; 50(2):114-27; discussion, 127-38. PubMed ID: 13324920
    [No Abstract]   [Full Text] [Related]  

  • 4. A CLINICAL TRIAL OF A NEW COMPOUND (DEHYDROEMETINE BISMUTH IODIDE, RO 4,3076) IN AMOEBIC DYSENTERY.
    SLADDEN DL; TAYLOR E; LIVINGSTONE DJ
    Cent Afr J Med; 1964 Nov; 10():412-3. PubMed ID: 14238732
    [No Abstract]   [Full Text] [Related]  

  • 5. [Use of a bismuth salt in the therapy of intestinal amebiasis].
    RAVAGLIA D
    G Sci Mediche; 1950 Feb; 5(2):33-4. PubMed ID: 15427894
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical trial of bismuth glycolyl arsenilate in intestinal amebiasis].
    LAHAM E
    Rev Med Moyen Orient; 1951; 8(1):96-9. PubMed ID: 14845243
    [No Abstract]   [Full Text] [Related]  

  • 7. A preliminary report on "wia" (a new bismuth-arsenical compound) in the treatment of amoebic dysentery.
    el DIN NOR el DIN G
    J Egypt Med Assoc; 1950; 33(5):518-20. PubMed ID: 15437535
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of intestinal amebiasis with bismuth glycolyl arsanilate.
    MILZER A; LEVY E; SOKNIEWICZ W
    Antibiotic Med Clin Ther (New York); 1956 Jan; 2(1):42-4. PubMed ID: 13283528
    [No Abstract]   [Full Text] [Related]  

  • 9. CLINICAL CONSIDERATIONS OF AMEBIASIS.
    MONAT HA
    Am J Gastroenterol; 1964 Apr; 41():353-5. PubMed ID: 14138145
    [No Abstract]   [Full Text] [Related]  

  • 10. Drug prophylaxis of amebiasis.
    BERBERIAN DA; DENNIS EW; KORNS RF; ANGELO CA
    J Am Med Assoc; 1952 Mar; 148(9):700-4. PubMed ID: 14897628
    [No Abstract]   [Full Text] [Related]  

  • 11. [More comments on amebiasis in Honduras].
    ARMANDO PAVON
    Rev Med Hondur; 1955; 23(172):894-901. PubMed ID: 13255278
    [No Abstract]   [Full Text] [Related]  

  • 12. [THE PROBLEM OF AMEBIASIS].
    IZAR G
    Arch Med Interna; 1963; 15():69-73. PubMed ID: 14078853
    [No Abstract]   [Full Text] [Related]  

  • 13. THE TREATMENT OF ACUTE AMOEBIC DYSENTERY: TRIALS OF DEHYDROEMETINE, OF DEHYDROEMETINE-BISMUTH-IODIDE, AND OF DEHYDROEMETINE AND DEHYDROEMETINE-BISMUTH-IODIDE IN COMBINATION.
    POWELL SJ; MACLEOD IN; WILMOT AJ; ELSDON-DEW R
    Ann Trop Med Parasitol; 1965 Jun; 59():205-7. PubMed ID: 14345285
    [No Abstract]   [Full Text] [Related]  

  • 14. The treatment of amoebiasis with milibis (bismuthoxy-para-Nglycolylarsanilate); preliminary report.
    PEREZ SANTIAGO E; HERNANDEZ MORALES F
    PR J Public Health Trop Med; 1950 Jun; 25(4):419-22; Spanish transl 423-7. PubMed ID: 15424336
    [No Abstract]   [Full Text] [Related]  

  • 15. The effectiveness of bismuthoxy-p-N-glycolylarsanilate (Win-1011) in the treatment of intestinal amoebiasis.
    BERBERIAN DA
    J Clin Invest; 1948 Jul; 27(4):525. PubMed ID: 18873806
    [No Abstract]   [Full Text] [Related]  

  • 16. Experimental chemoprophylaxis of amebiasis.
    BEAVER PC; JUNG RC; READ TR; ROBINSON TA; SHERMAN HJ
    Am J Trop Med Hyg; 1956 Nov; 5(6):1015-21. PubMed ID: 13381876
    [No Abstract]   [Full Text] [Related]  

  • 17. Histological observations on the influence of a special diet used in experimental amebiasis in guinea pigs.
    LYNCH JE
    Am J Trop Med Hyg; 1957 Sep; 6(5):813-9. PubMed ID: 13470200
    [No Abstract]   [Full Text] [Related]  

  • 18. [Bismuth glycolylarsanilate and fumagillin in therapy of intestinal amebiasis].
    DOERR ZAVALA E; TAG ESPINA F
    Rev Med Chil; 1954 Sep; 82(Suppl 5):37-44. PubMed ID: 13237675
    [No Abstract]   [Full Text] [Related]  

  • 19. The challenge of amoebiasis: understanding pathogenic mechanisms.
    Biagi F; Beltrán F
    Int Rev Trop Med; 1969; 3():219-39. PubMed ID: 4314342
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment of intestinal amebiasis with chloroquine with bismuth glycolylarsanilate and with fumagillin].
    FUENZALIDA JM; DAVILA M; PERALTA O; VARGAS H
    Rev Med Chil; 1955 Sep; 83(9):551-4. PubMed ID: 13298212
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.